Amongst Women Stratified to Receive Endocrine Therapy on the Basis of Their Tumor Estrogen and Progesterone Receptor Levels, Those with Higher Tumor Progesterone Receptor Levels Had a Better Outcome Than Those with Lower Levels of Tumor Progesterone Receptor.
Tai-Han LinHong-Wei GaoGuo-Shiou LiaoJyh-Cherng YuMing-Shen DaiJar-Yi HoCheng-Ping YuPublished in: Cancers (2021)
Patients with a PgR expression > 50% or an Allred score > 5 exhibited better 10-year BCSS and DFS.